Author:
M�nig H.,B�hm M.,Ohnhaus E. E.,Kirch W.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Reference22 articles.
1. .Abernethy DR, Greenblatt DJ, Ameer B, Shader RI (1985) Probenecid impairment of acetaminophen and lorazepam clearance. J Pharmacol Exp Ther 234: 345?349
2. Aherne GW, Piall E, Marks V, White WF (1978) Prolongation and enhancement of serum methothrexate concentrations by probenecid. Br Med J 1: 1097?1099
3. Andreasen F, Husted S (1980) The binding of furosemide to serum proteins in elderly patients: displacing effect of phenprocoumon. Acta Pharmacol Toxicol 47: 202?207
4. Boutin JA, Thomassin J, Siest G, Batt A (1984) Inhibition studies of microsomal UDP-glucuronosyltransferase activities by furosemide and salicylamide. Pharmacol Res Commun 16: 227?241
5. De Vries JX, Zimmermann R, Harenberg J (1986) Phenprocoumon metabolites in human plasma; characterization by HPLC and GC-MS. Eur J Clin Pharmacol 29: 591?594
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Antibacterial prescribing and warfarin: a review;British Dental Journal;2003-04
2. P;Hagers Handbuch der Pharmazeutischen Praxis;1994
3. Enzyme-inducing properties of probenecid in man [letter];British Journal of Clinical Pharmacology;1991-01
4. Drug glucuronidation in humans;Pharmacology & Therapeutics;1991-01